The FDA is raising the bar for approval of CAR T-cell therapies in oncology. | The FDA is raising the bar for approval of CAR ...

For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...

A collaborative effort among international research teams provides the most definitive statement yet on the usefulness of ...

Corticosteroids may cut short-term mortality in patients with severe pneumonia or acute respiratory distress syndrome (ARDS), ...

From machine learning to voting, the workings of the world demand randomisation, but true sources of randomness are ...

Modern neural networks, with billions of parameters, are so overparameterized that they can "overfit" even random, ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Sensitive tests designed to detect very small numbers of remaining leukemia cells after treatment, known as measurable ...

Alongside a strategy of subintimal tracking and re-entry, bringing patients back for stenting—early or late—offers similar ...

New medical research from heart and vascular experts at Intermountain Health is helping to improve heart care around the ...

Ianalumab (9 mg/kg) plus eltrombopag extended ITP disease control by 45% with patients maintaining disease control 2.8 times longer than with placebo plus eltrombopag1,262% of patients treated with ...

A session at the AHA Scientific Sessions 2025 focused on clinical trials related to cutting edge valve and coronary care.